Literature DB >> 15770699

The role of Notch and IL-7 signaling in early thymocyte proliferation and differentiation.

Gina Balciunaite1, Rhodri Ceredig, Hans-Jörg Fehling, Juan-Carlos Zúñiga-Pflücker, Antonius G Rolink.   

Abstract

We have analyzed the roles of Notch and IL-7 signaling in the proliferation and differentiation of mouse progenitor thymocyte subpopulations cultured on Notch delta-like-1 ligand-expressing OP9 stromal cells. Using bulk and limiting dilution cultures, we show that DN1 and DN2 cells require both Notch and IL-7 signaling for efficient proliferation and differentiation into cytoplasmic TCRbeta and surface TCRalpha/beta and TCRgamma/delta expressing T cells. Selection for cytoplasmic TCRbeta-positive cells is dependent on preTalpha expression. Both gamma/delta and alpha/beta TCR expressing T cells arising in culture can be efficiently stimulated by anti-CD3 cross-linking, suggesting that they might be functional. The differentiation of adult, but not fetal, DN1 and DN2 thymocytes into CD4 and/or CD8 expressing cells is inhibited by IL-7. Finally, efficient proliferation and differentiation of DN3 cells requires Notch signaling and preTCR expression, but is independent of IL-7.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15770699     DOI: 10.1002/eji.200425822

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  41 in total

1.  Immature T-cell clustering and efficient differentiation require the polarity protein Scribble.

Authors:  Kelly A Pike; Sarang Kulkarni; Tony Pawson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-28       Impact factor: 11.205

Review 2.  Forging T-Lymphocyte Identity: Intersecting Networks of Transcriptional Control.

Authors:  Ellen V Rothenberg; Jonas Ungerbäck; Ameya Champhekar
Journal:  Adv Immunol       Date:  2015-10-26       Impact factor: 3.543

3.  Propensity of adult lymphoid progenitors to progress to DN2/3 stage thymocytes with Notch receptor ligation.

Authors:  Jiaxue Huang; Karla P Garrett; Rosana Pelayo; Juan Carlos Zúñiga-Pflücker; Howard T Petrie; Paul W Kincade
Journal:  J Immunol       Date:  2005-10-15       Impact factor: 5.422

Review 4.  Progression of regulatory gene expression states in fetal and adult pro-T-cell development.

Authors:  Elizabeth-Sharon David-Fung; Mary A Yui; Marissa Morales; Hua Wang; Tom Taghon; Rochelle A Diamond; Ellen V Rothenberg
Journal:  Immunol Rev       Date:  2006-02       Impact factor: 12.988

5.  Bone marrow-derived mesenchymal stromal cells promote resistance to tyrosine kinase inhibitors in chronic myeloid leukemia via the IL-7/JAK1/STAT5 pathway.

Authors:  Xiaoyan Zhang; Huaijun Tu; Yazhi Yang; Xiaoyan Jiang; Xianliang Hu; Qidong Luo; Jian Li
Journal:  J Biol Chem       Date:  2019-06-24       Impact factor: 5.157

Review 6.  Cytokines, Transcription Factors, and the Initiation of T-Cell Development.

Authors:  Hiroyuki Hosokawa; Ellen V Rothenberg
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

Review 7.  Molecular mechanisms that control mouse and human TCR-alphabeta and TCR-gammadelta T cell development.

Authors:  Tom Taghon; Ellen V Rothenberg
Journal:  Semin Immunopathol       Date:  2008-10-17       Impact factor: 9.623

8.  High levels of IL-7 cause dysregulation of thymocyte development.

Authors:  Nahed El-Kassar; Francis A Flomerfelt; Baishakhi Choudhury; Lee A Hugar; Kevin S Chua; Veena Kapoor; Philip J Lucas; Ronald E Gress
Journal:  Int Immunol       Date:  2012-08-16       Impact factor: 4.823

9.  Core binding factors are necessary for natural killer cell development and cooperate with Notch signaling during T-cell specification.

Authors:  Yalin Guo; Ivan Maillard; Sankhamala Chakraborti; Ellen V Rothenberg; Nancy A Speck
Journal:  Blood       Date:  2008-04-04       Impact factor: 22.113

10.  T-cell differentiation of multipotent hematopoietic cell line EML in the OP9-DL1 coculture system.

Authors:  Snjezana Kutlesa; Jennifer Zayas; Alexandra Valle; Robert B Levy; Roland Jurecic
Journal:  Exp Hematol       Date:  2009-05-15       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.